Brand profile · Pharmaceutical Manufacturing

Cann Group

Cann Group is a Pharmaceutical Manufacturing brand in Melbourne, Victoria. Publicly held, at canngrouplimited.com. It holds three addresses on record, all in Australia. It employs 61 people, on the record. It lists agriculture, health and medicinal cannabis among its specialties. Two Australian registrations (ABN) are candidate matches. Its latest round on record is Series A, with no amount recorded. It is listed alongside nine similar brands, mostly in Pharmaceutical Manufacturing.

canngrouplimited.com LinkedIn

Profile live Public Company Founded 2017 2 registry matches ABN 1 office country 1 funding round
Registry match · ABR
Counted staff
61
self-reported 51–200 band
Founded
2017
9 years
Registry matches
2
ABR
Office countries
1
3 addresses
Funding rounds
1
Series A · May 2017
Company type
Public Company
self-reported
Use this profile Compare Your shortlist

Legal entities

1 brand → 2 possible registrationsThe join is a normalised name comparison against ABR. Treat every row below as a lead to verify, not as an established identity.

  • CANN GROUP LIMITED

    ABN25603949739

    VICMedium confidenceMatched on exact nameABR

  • CANN CORPORATION PTY LTD

    ABN52632587341

    QLDMedium confidenceMatched on exact nameABR

Legal entities

Cann Group: 2 registry entitiesCann Group is linked to 2 registry entities: CANN GROUP LIMITED (ABN 25603949739, candidate); CANN CORPORATION PTY LTD (ABN 52632587341, candidate).Cann GroupCANN GROUP LIMITEDABN 25603949739Candidate · Medium confidenceCANN CORPORATION PTYLTDABN 52632587341Candidate · Medium confidence
Show as table
CANN GROUP LIMITEDABN 25603949739
CANN CORPORATION PTY LTDABN 52632587341
Confirmed matches0 of 2

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Cann Group is a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and approved export markets. Cann has established research, cultivation and GMP manufacturing facilities in Bundoora, in northern Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group’s leading position in plant genetics, breeding, extraction, analysis and production techniques supports its objective to supply high quality, safe medicinal cannabis for a range of diseases and medical conditions. Incorporated in the Company's brand portfolio is its proprietary Satipharm delivery system for cannabinoids. Botanitech is a brand created by Cann and boasts a diverse, affordable and high-quality product range. The first stage of our new, state-of-the-art facility in regional Victoria is fully operational, with in-house analytical chemistry and microbiology laboratories, and the capacity to produce 12,500kg of high-quality flower per year, with subsequent stages planned in response to growing demand. We have extensive R&D collaborations with globally renowned agricultural and pharmaceutical research partners, and have developed our own exclusive, proprietary lines of high-yielding cultivars.

Cann Group is committed to the future of high-quality, low-cost cannabis medicines, and the development of a reliable and trusted industry.

Specialties

All 7 specialties
  • Agriculture
  • Research
  • Life Sciences
  • Health
  • Cannabis
  • Medicinal Cannabis
  • Cultivation

Related specialties

Locations

Australia

Country footprint

Offices in 1 countryCountry footprint: 1 country. Codes: AU.1 countryAU
Show as table
Countries1

All codes: AU

Addresses

  • AUWalter and Eliza Hall Institute; 4 Research Avenue; La Trobe University, Victora 3083
  • AUMelbourne, Victoria 3000Primary
  • AU4 Research Ave; Bundoora, Victoria 3083

Grid intelligence Members

Funding

Last round · 3 May 2017Amount not recordedSeries A
Rounds1
Round typeSeries A · venture round
Amount (USD)not recorded
Stage rank3
Investors named0
Since last round8 yr 8 mo

Funding

1 funding roundFunding timeline. Latest round 3 May 2017: Series A, amount not disclosed.20172026Series Aamount not disclosed1 round
Show as table
Rounds1
Axis2017 to 2026
Series A · 3 May 2017not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Notify me about spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend
Notify me about signals

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
Notify me about financials

People & contacts

4 employee profiles on record · names withheld.

The people relation is never requested, so there is nothing here to unlock.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entities operate under Cann Group?

Two Australian entities on the ABR: CANN GROUP LIMITED (ABN 25 603 949 739) and CANN CORPORATION PTY LTD (ABN 52 632 587 341). Both medium confidence.

How many people work at Cann Group?

61 counted staff profiles at January 2026, inside the self-reported 51–200 band.

Where does Cann Group have offices?

Three addresses on record, Australia only. Primary: Melbourne, Victoria 3000.

Has Cann Group raised funding?

One round. Latest 3 May 2017: Series A, no amount recorded.

What does Cann Group list as its specialties?

Seven tags on the brand's own list, among them agriculture, health and medicinal cannabis.

Which companies are listed alongside Cann Group?

Nine peer profiles on record: Green Farmers and ECS Botanics Holdings Ltd.

What is Cann Group's website?

canngrouplimited.com